Abstract
摘要
相似文献
1
Primary dysmenorrhoea and flufenamates.
N Z Med J. 1978 May 10;87(611):322.
2
Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea.
Lancet. 1978 Feb 18;1(8060):345-8. doi: 10.1016/s0140-6736(78)91077-2.
3
Dysmenorrhoea: effective new approaches to a controversial problem.
Med J Aust. 1980 Mar 22;1(6):248-9. doi: 10.5694/j.1326-5377.1980.tb134817.x.
4
A study of naproxen sodium and mefenamic acid in primary dysmenorrhoea.
Br J Clin Pract. 1983 Oct;37(10):342-7.
5
Clinical trial of the efficacy of mefenamic acid in relief of menorrhagia and/or dysmenorrhoea.
J Med Assoc Thai. 1983 Feb;66(2):99-105.
6
Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed.
Am J Obstet Gynecol. 1984 Jan 1;148(1):96-103. doi: 10.1016/s0002-9378(84)80039-3.
7
Comparison of the effectiveness of fennel and mefenamic acid on pain intensity in dysmenorrhoea.
East Mediterr Health J. 2006 May-Jul;12(3-4):423-7.
8
A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea.
Br J Clin Pract. 1989 Sep;43(9):317-21.
9
[Drug therapy of dysmenorrhea].
Gynakologe. 1988 Mar;21(1):58-62.
10
[Mefenamic acid in primary dysmenorrhea].
Ginecol Obstet Mex. 1981 Jan;48(291):33-6.
Zotero 插件